Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-free versus opioid-based anesthesia in elderly patients undergoing unilateral knee arthroplasty
ChiCTR2300069836Phase 4Completed
- Sponsor
- The Affiliated Hospital of Jiaxing University
- Start
- Apr 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine, sufentanil and remifentanil in knee osteoarthritis (OA), sponsored by The Affiliated Hospital of Jiaxing University. Primary endpoint: Proportion of NK cells in total lymphocytes. Started Apr 2023; status: completed.
02
Drugs
esketaminesufentanilremifentanil
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2300069836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069836.